| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bivalent mRNA SARS-CoV-2 vaccination in patients with inflammatory bowel disease
|
Quan, Joshua
|
|
|
8 |
12 |
p. 1074-1075
|
artikel
|
| 2 |
Correction to Lancet Gastroenterol Hepatol 2023; 8: 1058–59
|
|
|
|
8 |
12 |
p. e9
|
artikel
|
| 3 |
Death in the Blood
|
Burki, Talha
|
|
|
8 |
12 |
p. 1078
|
artikel
|
| 4 |
DEI in gastroenterology and hepatology
|
The Lancet Gastroenterology & Hepatology,
|
|
|
8 |
12 |
p. 1057
|
artikel
|
| 5 |
Does phlebotomy in people with haemochromatosis become history?
|
Swinkels, Dorine W
|
|
|
8 |
12 |
p. 1063-1064
|
artikel
|
| 6 |
Efruxifermin in non-alcoholic steatohepatitis
|
Mahgoub, Sara
|
|
|
8 |
12 |
p. 1058-1059
|
artikel
|
| 7 |
Heart–liver axis implications of the new steatotic liver disease nomenclature
|
Li, Pengfei
|
|
|
8 |
12 |
p. 1071-1072
|
artikel
|
| 8 |
Improving equity and access to bariatric surgery
|
Johnson-Mann, Crystal
|
|
|
8 |
12 |
p. 1068-1070
|
artikel
|
| 9 |
Kris Kowdley: the renaissance hepatologist
|
Kirby, Tony
|
|
|
8 |
12 |
p. 1079
|
artikel
|
| 10 |
Less is more: rethinking colorectal cancer resection strategies in Lynch syndrome
|
Katona, Bryson W
|
|
|
8 |
12 |
p. 1061-1063
|
artikel
|
| 11 |
Liver disease admissions in the UK are increasing, urgently needing local and national solutions
|
Bhala, Neeraj
|
|
|
8 |
12 |
p. 1071
|
artikel
|
| 12 |
Liver transplantation for people of minoritised sexual and gender identities in the USA
|
Lee, Tzu-Hao
|
|
|
8 |
12 |
p. 1152-1162
|
artikel
|
| 13 |
Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study
|
Eikenboom, Ellis L
|
|
|
8 |
12 |
p. 1106-1117
|
artikel
|
| 14 |
Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review
|
Pathiyil, Mythili Menon
|
|
|
8 |
12 |
p. 1143-1151
|
artikel
|
| 15 |
Research in Brief
|
Baker, Holly
|
|
|
8 |
12 |
p. 1077
|
artikel
|
| 16 |
Rusfertide for the treatment of iron overload in HFE-related haemochromatosis: an open-label, multicentre, proof-of-concept phase 2 trial
|
Kowdley, Kris V
|
|
|
8 |
12 |
p. 1118-1128
|
artikel
|
| 17 |
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trial
|
Noureddin, Mazen
|
|
|
8 |
12 |
p. 1094-1105
|
artikel
|
| 18 |
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
|
Harrison, Stephen A
|
|
|
8 |
12 |
p. 1080-1093
|
artikel
|
| 19 |
The British Association for the Study of the Liver commitment to equality, diversity, and inclusivity
|
Jones, Rebecca
|
|
|
8 |
12 |
p. 1066-1068
|
artikel
|
| 20 |
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
|
Hilmi, Marc
|
|
|
8 |
12 |
p. 1129-1142
|
artikel
|
| 21 |
The potential of ctDNA in locoregional therapies for colorectal cancer
|
Boeken, Tom
|
|
|
8 |
12 |
p. 1072-1073
|
artikel
|
| 22 |
UEG Week 2023
|
Thomas, Hugh
|
|
|
8 |
12 |
p. 1076
|
artikel
|
| 23 |
Uncouplers of mitochondrial oxidation in non-alcoholic fatty liver disease
|
Michel, Maurice
|
|
|
8 |
12 |
p. 1060-1061
|
artikel
|
| 24 |
What is the current status of multicancer early detection tests and upper gastrointestinal cancer?
|
Hoare, Matt
|
|
|
8 |
12 |
p. 1065-1066
|
artikel
|
| 25 |
WHO awards Egypt with gold tier status on the path to eliminate hepatitis C
|
Hassany, Mohamed
|
|
|
8 |
12 |
p. 1073-1074
|
artikel
|
Tijdschrift beschrijving